Anti-insulin growth factor receptor therapy in Ewing sarcoma

Por Isakoff, Michael S, Marina, Neyssa
Publicado em 2009

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Por Isakoff, Michael S., Bielack, Stefan S., Meltzer, Paul, Gorlick, Richard
Publicado no J Clin Oncol (2015)

Poor Survival for Osteosarcoma of the Pelvis: A Report from the Children’s Oncology Group

Por Isakoff, Michael S., Barkauskas, Donald A., Ebb, David, Morris, Carol, Letson, G. Douglas
Publicado em 2012

Rapid Protocol Enrollment in Osteosarcoma: a report from the Children’s Oncology Group

Por Isakoff, Michael S., Goldsby, Robert, Villaluna, Doojduen, Krailo, Mark D., Gorlick, Richard, Doski, John J., Womer, Richard B., Janeway, Katherine A.
Publicado no Pediatr Blood Cancer (2015)

Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation

Por Isakoff, Michael S., Sansam, Courtney G., Tamayo, Pablo, Subramanian, Aravind, Evans, Julia A., Fillmore, Christine M., Wang, Xi, Biegel, Jaclyn A., Pomeroy, Scott L., Mesirov, Jill P., Roberts, Charles W. M.
Publicado em 2005

FEASIBILITY AND DOSE DISCOVERY ANALYSIS OF ZOLEDRONIC ACID WITH CONCURRENT CHEMOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED METASTATIC OSTEOSARCOMA: A REPORT FROM THE CHILDEREN’S O...

Por Goldsby, Robert E., Fan, Timothy M., Villaluna, Doojduen, Wagner, Lars M., Isakoff, Michael S., Meyer, James, Randall, R. Lor, Lee, Sharon, Kim, Grace, Bernstein, Mark, Gorlick, Richard, Krailo, Mark, Marina, Neyssa
Publicado em 2013

Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies

Por Reed, Damon R., Mascarenhas, Leo, Manning, Kathleen, Hale, Gregory A., Goldberg, John, Gill, Jonathan, Sandler, Eric, Isakoff, Michael S., Smith, Tiffany, Caracciolo, Jamie, Lush, Richard M., Juan, Tzu‐Hua, Lee, Jae K., Neuger, Anthony M., Sullivan, Daniel M.
Publicado no Cancer Med (2015)

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Por Hijiya, Nobuko, Thomson, Blythe, Isakoff, Michael S., Silverman, Lewis B., Steinherz, Peter G., Borowitz, Michael J., Kadota, Richard, Cooper, Todd, Shen, Violet, Dahl, Gary, Thottassery, Jaideep V., Jeha, Sima, Maloney, Kelly, Paul, Jo-Anne, Barry, Elly, Carroll, William L., Gaynon, Paul S.
Publicado em 2011

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Por Robison, Nathan J, Campigotto, Federico, Chi, Susan N, Manley, Peter E, Turner, Christopher D, Zimmerman, Mary Ann, Chordas, Christine A, Werger, Annette M, Allen, Jeffrey C, Goldman, Stewart, Rubin, Joshua B, Isakoff, Michael S, Pan, Wilbur J, Khatib, Ziad A, Comito, Melanie A, Bendel, Anne E, Pietrantonio, Jay B, Kondrat, Laura, Hubbs, Shannon M, Neuberg, Donna S, Kieran, Mark W
Publicado no Pediatr Blood Cancer (2014)

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international,...

Por Marina, Neyssa M, Smeland, Sigbjørn, Bielack, Stefan S, Bernstein, Mark, Jovic, Gordana, Krailo, Mark D, Hook, Jane M, Arndt, Carola, van den Berg, Henk, Brennan, Bernadette, Brichard, Bénédicte, Brown, Ken L B, Butterfass-Bahloul, Trude, Calaminus, Gabriele, Daldrup-Link, Heike E, Eriksson, Mikael, Gebhardt, Mark C, Gelderblom, Hans, Gerss, Joachim, Goldsby, Robert, Goorin, Allen, Gorlick, Richard, Grier, Holcombe E, Hale, Juliet P, Hall, Kirsten Sundby, Hardes, Jendrik, Hawkins, Douglas S, Helmke, Knut, Hogendoorn, Pancras C W, Isakoff, Michael S, Janeway, Katherine A, Jürgens, Heribert, Kager, Leo, Kühne, Thomas, Lau, Ching C, Leavey, Patrick J, Lessnick, Stephen L, Mascarenhas, Leo, Meyers, Paul A, Mottl, Hubert, Nathrath, Michaela, Papai, Zsuzsanna, Randall, R Lor, Reichardt, Peter, Renard, Marleen, Safwat, Akmal Ahmed, Schwartz, Cindy L, Stevens, Michael C G, Strauss, Sandra J, Teot, Lisa, Werner, Mathias, Sydes, Matthew R, Whelan, Jeremy S
Publicado no Lancet Oncol (2016)